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Summary The uptake, retention and effects of aluminium chloro sulphonated phthalocyanine (AlSPc) were
measured in two cell lines, UV-2237 a murine fibrosarcoma and the non-tumorigenic NIH/3T3 fibroblast line.
The behaviour of cells treated with AlSPc was compared with that of those treated with haematoporphyrin
derivative (HpD), a photosensitizer often used in photodynamic therapy (PDT) of cancer.
AlSPc absorbs light strongly in the red region, is taken up by cells in a dose dependent fashion and is
retained in vitro over a period of days (5 days after exposure >40% remains cell-associated versus <25% of
HpD). Additionally AlSPc was less cytotoxic to cells, maintained in darkness or exposed to room light,
compared to HpD (100% viability versus 0% viability 3 days after 60min exposure to room light). However
red light (-600-700nm) caused greater toxicity in AlSPc-treated cells (100%) than in similarly exposed HpD-
treated cells (<60%). No significant differences were detected between the responses of the fibrosarcoma and
the fibroblast cell lines. These characteristics of AlSPc suggest that it may prove to be a useful photosensitizer
for PDT of cancer and this possibility is discussed.
Photodynamic therapy (PDT) of cancer is a
relatively new technique that has been used
clinically for the treatment of a variety of
neoplasms. The basis of the technique is the
systemic administration of photosensitizing dyes
which localize to, or are retained preferentially by,
the neoplastic lesion; the tumour is then exposed to
light of the appropriate wavelength which photo-
activates the dye leading to the generation of cyto-
toxic products. Selectivity of effect is a consequence
of both the preferential accumulation of the dye
and the accuracy of light delivery.
At the present time the photosensitizer of choice
in PDT is haematoporphyrin derivative (HpD)
which shows preferential tumour localizing ability
in a wide variety of human tumours (Lipson et al.,
1961; Gregorie et al., 1968; Leonard & Beck, 1971;
Profio & Doiron, 1977; Kinsey et al., 1978; Benson
et al., 1982). The tumoricidal effect of HpD
following light exposure is generally attributed to
the formation of singlet oxygen generated by the
transfer of energy from the excited HpD to tissue
oxygen (Weishaupt et al., 1976; Moan et al., 1979).
While the reasons for the preferential accumulation
of HpD in neoplastic tissue, and even the exact
basis of its anti-tumour effects, remain to be
elucidated it has been used in the treatment of
human cancer (Kelly & Snell, 1976; Dougherty et
al., 1978; Dougherty et al., 1979; Forbes et al.,
1980; Hayata et al., 1980; Dahlman et al., 1983; Ha
et al., 1983; Carruth et al., 1985). However, HpD
has many characteristics which make it less than an
ideal photosensitizer. HpD is formed by the
treatment of haematoporphyrin with a mixture of
acetic and sulphuric acid (Lipson et al., 1961); a
procedure which gives rise to a number of
components. Several investigators have tried to
determine the active component of HpD, and
several candidate substances have been identified
(Berenbaum et al., 1982; Dougherty & Weishaupt,
1983; Evensen et al., 1984; Kessel & Cheng, 1985).
However, these components have not been
chemically purified. The disadvantages of
attempting to work clinically with a complex
mixture of substances, whose composition may vary
from batch to batch, are compounded by the fact
that HpD may aggregate to different extents in
different environments with resultant alterations in
biological efficacy (Dougherty et al., 1983).
Furthermore, HpD absorbs red light poorly. This is
a major disadvantage in treatment where it is
desirable to use red light (absorbance 600-700nm)
for optimal tissue penetration. Finally, an
additional complication is that patients receiving
HpD for PDT often suffer from photosensitive
reactions to daylight as a consequence of the
retention of appreciable amounts of dye in the skin
(Dougherty et al., 1979).
These limitations have, in part, restricted the
development of PDT and underlay the search for
alternative photosensitive compounds for clinical
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use. In the present study we report on some of the
characteristics of aluminium chloro sulphonated
phthalocyanine (AlSPc), whose effects we have
examined in tissue culture and compared to the
more commonly used HpD.
Materials and methods
Preparation ofphotosensitizers
Aluminium chloro sulphonated phthalocyanine
(AlSPc) AlSPc was obtained from Ciba-Geigy
Dyestuffs and Chemicals (Postfach, Basel,
Switzerland) and used as received. Sulphonation
was reported to have been achieved by the action of
fuming sulphuric acid on the metallophthalocyanine
resulting in an average of three sulphonic acid
groups per molecule (McCubbin, 1985). Isomers of
this compound may be present and work is in
progress to simplify this mixture though in
molecular terms this substance is more
homogeneous than HpD.
A stock solution was prepared by dissolving the
compound in phosphate buffered saline (PBS) at
5mgml-1 concentration. Aliquots were stored
below 10°C in the dark, and added to growth
medium to a final concentration immediately prior
to use; this final solution was filtered, for sterility,
through a 0.2gm filter (Nalgene).
Haematoporphyrin derivative (HpD) Haematopor-
phyrin was obtained in its impure state from Sigma
Chemical Company, purified by standard techniques
(Brault et al., 1984) and was treated with acetic and
sulphuric acid as outlined by Lipson et al., 1961.
Once made the compound was dried and stored as
a solid below 0°C in the dark.
Stock solutions were prepared by dissolving the
final product in 0.1N NaOH, pH was adjusted to
7.4 with 0.1 NHC1 and PBS was added to
5mgml- I concentration. Solutions were stored
below 10°C in the dark and brought to a final
concentration and treated exactly as described for
AlSPc.
Cell lines and culture conditions
Two murine cell lines, NIH/3T3 and UV-2237, were
used in this study. NIH/3T3 cells, derived from a
Balb/c mouse, generally are considered to be non-
tumorigenic (Aaronson & Todaro, 1968) though
tumorigenic conversion may occur following
prolonged cultivation in tissue culture (Greig et al.,
1985). UV-2237 is an ultraviolet light-induced fibro-
sarcoma of C3H/He mice (Kripke et al., 1978).
Both lines were grown on tissue culture plastic in
E-4 growth medium, supplemented with 10% heat-
inactivated foetal calf serum, at 370C in 5% CO2
and a humidified atmosphere. Because of
differences in cell size the larger NIH/3T3 cells were
grown in 90mm petri dishes (Nunc) with 7-10ml
medium whereas UV-2237 were grown in 55mm
petri dishes containing 3-4ml medium.
Photosensitizer uptake studies
Cells (NIH/3T3, 1.5 x 105-7.5 x 105; UV-2237,
3x105-1.5x 106) were plated in growth medium
overnight for attachment. The next day medium
was aspirated off and the cells were refed with
medium containing either AlSPc or HpD at
concentrations varying from 5,ug to 100 gml- .
All procedures were performed in as close to
complete darkness as possible with the laminar-flow
hood enclosed within a dark curtain and light
provided by a single bunsen-burner. When stored in
incubators, petri dishes containing cells were
protected from light by wrapping in aluminium foil.
After 3 days' growth adherent cells were washed
3 times with PBS. Proteins and cell-associated
sensitizers were extracted with either 0.1 N NaOH
(5-10ml/dish) directly from the cell monolayer or
with 0.5% Triton X-100 (in 10mM Tris buffer,
pH8.3) from a trypsinized cell pellet. Triton X-100
extracts subsequently were subjected to sonication
for two minutes. Both extraction procedures gave
essentially identical results (data not shown). Both
NaOH and Triton X-100 extracts were stored at
-20°C before use. Protein was estimated by the
Lowry method and fluorescence intensity was
measured in a Perkin Elmer MPF-5 spectrofluoro-
meter using these settings: AlSPc, excitation, 350-
360nm; emision, 670-680nm. HpD, excitation,
395-405nm; emission, 615-625nm. Two dishes
were used per time point in an experiment and
individual values presented were obtained from the
mean of 2-3 separate experiments. The amount of
cell-associated photosensitizer was expressed as
fluorescence units per 100,ug of cellular protein.
Over the protein concentrations used in our studies
we were unable to demonstrate quenching of any
values obtained in a standard curve and thus
assume that fluorescence is a measure of dye
concentration.
The kinetics of cellular uptake of AlSPc and
HpD were determined with NIH/3T3 cells. Cells
plated as detailed above were then exposed to the
photosensitizers at a concentration of 25 igml-1
medium. At the recorded time points cells were
extracted with NaOH and protein and fluorescence
intensity were measured as described above.
Cellular retention ofphotosensitizers
NIH/3T3 (7.5 x 105) and UV-2237 (1.5 x 106) cells
were treated with photosensitizers at a concen-
tration of 25,ugml-1 medium. After 24h, cells were
washed with PBS and refed with sensitizer-freeIN VITRO STUDIES OF PHTHALOCYANINE AND HAEMATOPORPHYRIN DERIVATIVES 257
medium daily. Cellular proteins and cell-associated
photosensitizer were determined in Triton X-100
extracts at the recorded time points over 5 days.
Replicate plates were harvested by treatment with
0.25% trypsin and total cell numbers were
determined using a Coulter Counter (Coulter
Electronics).
Cytotoxicity determinations
The cells were treated with photosensitizers as
described for the uptake experiments with sensitizer
concentrations varying from 0 to 300pgml- I
medium. Following treatment, cell monolayers were
washed several times with PBS to remove all non-
adherent cells. With the two cell lines used viable
cells are adherent while dead cells as well as those
in mitosis, detach from the substrate. Monolayers
were trypsinized and the number of surviving cells
were determined by Coulter counting. As far as
possible all procedures were performed in near
darkness to measure the inherent toxicity of HpD
and AlSPc.
Photo-dependent cytotoxicity
NIH/3T3 (1-5 x 105 cells/dish) and UV-2237 2-
5 x 105 cells/dish) were prepared as described pre-
viously. Following treatment with photosensitizers
at 25pgml-1 concentration for 24h the medium
was removed and replaced by PBS (containing
Mg+ + and Ca++). Cells were either exposed to
ordinary room light or irradiated under red light
for 0 to 60min. After exposure to light the cells
were refed with fresh growth medium and were
cultured in the dark for a further 3 days. Surviving
cells were estimated by Coulter counting as
described above.
Room light was derived from the output of
several white light fluorescent tubes, together with
normal daylight.
Red light was derived from a bank of four
fluorescent tubes (Applied Photophysics, 14W
each). The light emitted from this source was
filtered through a red gelatin filter (182 light red
Y= 11.04%, Lee Filters Limited, Andover, UK)
allowing transmission of light >600nm and then
diffused with a sheet of grease proof paper to
achieve greater uniformity of irradiation of the cells
(5.5 cm from source).
The spectra of each light source were determined
by an LS-3 Perkin Elmer Spectrofluorometer and
are given in Figure 1. The intensity of room and
red lights measured at the cells' location was
0.19Wm-2 and 0.71 Wm-2, respectively. These
values were determined by a Spectra Physics 404
Power Meter.
One hour's incubation under red light irradiation
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Figure 1 Emission spectra of room light (---) and
red light ( ).
caused a temperature rise from 22°C at Omin to
30°C at 60min, well below the normal incubation
temperature of the cells. We therefore presume that
observed cytotoxicity was a consequence of photo-
activation rather than a result of hyperthermia; a
conclusion supported by the lack of cytotoxicity
associated with red light exposure only (i.e. minus
photosensitizer).
Fluorescence microscopy
Undehydrated formalin fixed photosensitizer-treated
cells were examined with a Zeiss photomicro-
scope equipped for epifluorescence using 487702
filter set for AlSPc and 487704 filter set for HpD.
Micrographs were taken using Kodak Ektachrome
200 film.
Results
The chemical structure of AlSPc is presented in
Figure 2. Absorption spectra of AlSPc and HpD
r1
Figure 2 Structure of aluminium chloro sulphonated
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confirmed that the main absorption wavelength of
AlSPc lies in the UV and red light regions, whereas
HpD responds to shorter wavelengths especially in
the UV region (Figure 3).
Both AlSPc and HpD were taken up by the cells
as shown in a fluorescence micrograph (Figure 4). In
HpD- or AlSPc-treated NIH/3T3 cells fluorescence
was distributed mainly in the area outside the
nucleus. All quantitative data presented were
derived from mean values of 2 or 3 individual
experiments with duplicate samples measured at
each value point; standard errors were <10% for
all results.
Uptake of both AlSPc and HpD is a dose
dependent phenomenon (Figure 5). There was no
consistent difference between NIH/3T3 and UV-
2237 cells in HpD uptake; whereas AISPc was
consistently shown to be taken up in relatively
greater amounts by the non-tumorigenic NIH/3T3
cells as compared to the tumorigenic UV-2237 cells.
However, these differences in uptake while
consistently reproducible were not significant.
Figure 6 shows the kinetics of AlSPc and HpD
uptake in NIH/3T3 cells. AlSPc uptake is a cont-
inuous process so that after 3 days incubation the
plateau concentration of AlSPc had not been
attained. This is in contrast to the biphasic pattern
of HpD uptake which exhibits rapid initial incor-
poration into the cells followed by a slower uptake
approaching plateau concentrations after 12h.
The patterns of uptake for AlSPc and HpD were
similar with UV-2237 cells to those determined with
NIH/3T3 cells (data not shown).
Relatively greater amounts of AlSPc than HpD
were taken up by both cell types (Figure 6).
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Figure 4 Fluorescence micrographs of NIH/3T3 cells
following exposure to photosensitizers (25 ugml-1) for
3 days. (a) AlSPc; (b) HpD.
500 600
Wavelength
Figure 3 Absorbance spectra of AlSPc, 5ygml-'
and HpD, A=5,ugml-', B=50pgml-1 (_
foetal calf serum (2 mm cell path length).
Cellular retention of both AlSPc and HpD is
shown in Figure 7. UV-2237 is a rapidly growing
cell line and, being transformed, confluency does
not prevent cell division (Figure 8) so that in order
to compare results obtained for this line with those
derived for the slower growing, contact-inhibited
NIH/3T3 cells (Figure 8) photosensitizer clearance
was expressed as the fluorescence intensity of total
cells per dish rather than as fluorescence intensity
ig-1 cellular protein. However, cell division will
dilute away the amounts of photosensitizer per cell
without there being a true loss of cell associated --- ~~--
--_---__1
700 sensitizers. These considerations make it difficult to
compare accurately the retention of the photo-
sensitizers by the UV-2237 and the NIH/3T3 cells.
--) in It is apparent that AlSPc was lost gradually so
that after 5 days, over 40% of initial cell-associated
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Figure 5 Cellular uptake of(a)AlSPcand (b) HpD. (0) NIH/3T3; (0) UV-2237. Techniques as described in the
text).
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Figure 6 Kinetics of AlSPc (0) and HpD (0) uptake
in NIH/3T3 cells. Medium contained photosensitizer
at 25 ugml -I concentration.
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Figure 7 Kinetics of AlSPc ( ) and HpD (---)
retention in cells. Cells were exposed to photosensitizer
(25ygml-1) for 24h before examination for retention.
(0) NIH/3T3; (0) UV-2237.
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Figure 8 Cell growth following removal of
photosensitizer from medium. (0) AlSPc-treated cells;
(0) HpD-treated cells.
AlSPc still remained in the cells (Figure 7). In
contrast, HpD was lost from the cells at a
considerably faster rate than AlSPc. Thus, after 2
days, only a small fraction (<25%) of the
compound remained associated with the cells;
however, this small portion seemed to be retained
by the cells for an extended period (Figure 7). Even
allowing for the difficulties stated above there
appeared to be no significant difference in photo-
sensitizer retention between the two cell types.
The inherent cytotoxicity of AlSPc and HpD
(obtained for non light exposed cells) is shown in
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Figure 9. The cytotoxic effect of both photo-
sensitizers is dose-dependent. AISPc appears to be
considerably less toxic than HpD. When NIH/3T3
and UV-2237 cells are compared, both have similar
susceptibilities to the photosensitizers.
The sensitivity of photosensitizer-treated cells to
the two light sources used in this study is illustrated
in Figure 10. No calibration of the absolute
incident light intensities corresponding to the
a
absorption range of HpD and AlSPc was
performed. However, AlSPc-treated cells manifested
no detectable response to 60min exposure to room
light, whereas HpD-treated cells exposed to the
same light for just 30min showed essentially no
survival when assessed 3 days later. In contrast
when red light was used to photoilluminate cells the
sensitivity of the treated cells was reversed. Thus a
30min exposure of AlSPc-treated cells produced
b
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Figure 9 Cytotoxicity of photosensitizers. (a) NIH/3T3; (b) UV-2237; (0) AlSPc; (0) HpD. Untreated cells
recovery expressed as 1.0.
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Figure 10 Photodynamic dependent cytotoxicity of photosensitizers to cells. (a) NIH/3T3; (b) UV-2237. Cells
were exposed to photosensitizer (25Mgml-1) prior to irradiation as described in text. Untreated cells were
coirradiated under room light and red light for 60min; both treatments of control cells gave equal cell yields
which are expressed as 1.0 in the figure. (0) AlSPc-treated cells; (0) HpD-treated cells; (- ) room light,
(---) red light).
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0% survival at day 3 (confirmed by failure to
develop colonies up to two weeks after treatment)
whereas HpD treated cells under the identical
conditions had a survival rate of >40%. Again,
there were no differences between NIH/3T3 and
UV-2237 cells with regard to their susceptibilities to
these treatments.
Discussion
In the present study we report on some of the
characteristics of aluminium chloro sulphonated
phthalocyanine (AlSPc), a compound which has
potential as a photosensitizer for use in PDT of
cancer. Preliminary work already has demonstrated
selective localization and retention of AlSPc in two
rat tumours (S. Bown and C. Tralau, personal
communication) and therefore we have examined
some in vitro characteristics of this compound. In
order to provide a basis for evaluation we have
compared AlSPc with HpD, the substance most
often used in PDT at the present time. One of the
disadvantages of HpD is the variability in its com-
position resulting from different modes of
preparation. It is therefore important to note that
the HpD used in these experiments gave
comparable absorption spectra (Gomer & Smith,
1980; Kinsey et al., 1981), kinetics of cellular
uptake and retention (Berns et al., 1982; Henderson
et al., 1983), cytotoxicity (Moan et al., 1983) and
intracellular fluorescence (Berns et al., 1982) to that
reported from other laboratories.
AlSPc shares many features with HpD in the in
vitro assays performed here but it also possesses
some attributes which potentially make this
compound a more suitable photosensitizer. AlSPc,
which is synthesized relatively easily by the action
of fuming sulphuric acid on the metallophthalo-
cyanine, is stable, readily soluble in water producing
essentially monomeric species (McCubbin, 1985),
has a good fluorescence quantum yield (0.58),
a long lived triplet state (510+50us, pH7.4)
capable of undergoing bimolecular quenching to
produce a reactive species and a strong Q band
absorption at 675nm (Figure 2).
The ideal photosensitizer should be non-toxic and
preferably show some propensity for selective
uptake or retention by tumour cell. In this
regard, it is perhaps disappointing that no
difference in uptake or retention was achieved
between the 'normal' NIH/3T3 fibroblasts and the
transformed UV-2237 cells. However, a similar
failure to discriminate between the two cell types
was manifested by HpD, a photosensitizer of
proven efficacy in PDT. It has been suggested that
selective accumulation of porphyrin compounds in
neoplastic tissues is a consequence of the increased
cellular proliferation in tumours (Figge et al., 1948).
Our results are not in agreement with this
hypothesis since the relatively slow growing
NIH/3T3 cells were able to take up and retain HpD
to a similar extent as the faster growing UV-2237
cells. Other experiments using tissue culture lines
also have failed to show selective differences in
HpD uptake by normal and malignant cells (Chang
& Doughtery, 1978; Henderson et al., 1983) and
more recent in vivo experiments have suggested that
HpD may exert its anti-neoplastic effect via
mechanisms unrelated to selective retention by
individual tumour cells. Specifically it has been
suggested that tumour destruction by PDT is
mediated via primary damage to the tumour
vasculature (Bugelski et al., 1981; Selman et al.,
1984; Star et al., 1984; Henderson et al., 1985).
Thus the apparent lack of specificity in AlSPc
uptake, as determined in vitro, may not be a vital
factor in limiting clinical use. In vivo experiments to
test this possibility are currently underway in our
laboratories. Perhaps of greater importance in this
regard is the fact that, in spite of being taken up to
a relatively greater extent and being retained for a
longer period of time than HpD, AlSPc was
innately less toxic to the cells both in darkness and
following exposure to room light. These preliminary
observations may augur well for a reduction in the
undesirable side effects of photosensitization that
may be associated with PDT. That AlSPc has the
capacity to be used as a therapeutic agent in this
mode of treatment is suggested by the enhanced
photokilling obtained by red light activation; a
differential response to light illumination that may
enhance the clinical utility of this compound.
The potential of phthalocyanines for use as
photosensitizers is becoming recognized (Rousseau
et al., 1983; Ben-Hur et al., 1985a,b). In this report
we show that a member of this family of
compounds, AlSPc, has many characteristics that
make it an attractive candidate for use in PDT.
Further investigations currently are in progress to
determine the feasibility of using this agent in the
treatment of cancer.
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